GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stallergenes Greer PLC (GREY:STLLF) » Definitions » Gross Margin %

Stallergenes Greer (Stallergenes Greer) Gross Margin % : 61.10% (As of Dec. 2018)


View and export this data going back to 2013. Start your Free Trial

What is Stallergenes Greer Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Stallergenes Greer's Gross Profit for the six months ended in Dec. 2018 was $93.61 Mil. Stallergenes Greer's Revenue for the six months ended in Dec. 2018 was $153.21 Mil. Therefore, Stallergenes Greer's Gross Margin % for the quarter that ended in Dec. 2018 was 61.10%.

Warning Sign:

Stallergenes Greer PLC gross margin has been in long term decline. The average rate of decline per year is -4.3%.


The historical rank and industry rank for Stallergenes Greer's Gross Margin % or its related term are showing as below:

STLLF' s Gross Margin % Range Over the Past 10 Years
Min: 53.6   Med: 77.19   Max: 81.14
Current: 64.66


During the past 13 years, the highest Gross Margin % of Stallergenes Greer was 81.14%. The lowest was 53.60%. And the median was 77.19%.

STLLF's Gross Margin % is not ranked
in the Biotechnology industry.
Industry Median: 60.63 vs STLLF: 64.66

Stallergenes Greer had a gross margin of 61.10% for the quarter that ended in Dec. 2018 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Stallergenes Greer was -4.30% per year.


Stallergenes Greer Gross Margin % Historical Data

The historical data trend for Stallergenes Greer's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stallergenes Greer Gross Margin % Chart

Stallergenes Greer Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76.82 53.60 54.22 63.70 64.66

Stallergenes Greer Semi-Annual Data
Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.25 64.31 63.10 68.02 61.10

Competitive Comparison of Stallergenes Greer's Gross Margin %

For the Biotechnology subindustry, Stallergenes Greer's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stallergenes Greer's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stallergenes Greer's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Stallergenes Greer's Gross Margin % falls into.



Stallergenes Greer Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Stallergenes Greer's Gross Margin for the fiscal year that ended in Dec. 2018 is calculated as

Gross Margin % (A: Dec. 2018 )=Gross Profit (A: Dec. 2018 ) / Revenue (A: Dec. 2018 )
=203.8 / 315.191
=(Revenue - Cost of Goods Sold) / Revenue
=(315.191 - 111.396) / 315.191
=64.66 %

Stallergenes Greer's Gross Margin for the quarter that ended in Dec. 2018 is calculated as


Gross Margin % (Q: Dec. 2018 )=Gross Profit (Q: Dec. 2018 ) / Revenue (Q: Dec. 2018 )
=93.6 / 153.207
=(Revenue - Cost of Goods Sold) / Revenue
=(153.207 - 59.597) / 153.207
=61.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Stallergenes Greer  (GREY:STLLF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Stallergenes Greer had a gross margin of 61.10% for the quarter that ended in Dec. 2018 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Stallergenes Greer Gross Margin % Related Terms

Thank you for viewing the detailed overview of Stallergenes Greer's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Stallergenes Greer (Stallergenes Greer) Business Description

Traded in Other Exchanges
N/A
Address
40 Bernard Street, 3rd Floor, London, GBR, WC1N 1LE
Stallergenes Greer PLC is a pharmaceutical company. The company treats severe allergic rhinitis with allergen immunotherapy. Its portfolio comprises of Sublingual products, Subcutaneous products, Veterinary products and Other. The sublingual products are offered under the brand name Staloral and Oralair. The Subcutaneous products include Phostal, Alustal, Alyostal, Albey. The company also offers enzyme-linked immunosorbent assay components and prescription services. It provides skin testing devices enabling the identification of the allergen or allergens responsible for the allergy, sterile diluents and sterile empty vials, syringes, and other compendial products. The company operates in internationally and geographically generates maximum revenue from the United States.

Stallergenes Greer (Stallergenes Greer) Headlines

No Headlines